A set of ~800 largely isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Designed to fill gaps in deletion coverage and breakpoint placement; also used to replace older available deficiencies that have not been molecularly mapped.
Df(3R)BSC789/Df(3R)BSC806 first instar larvae do not show any dorsal closure defects, although head development is abnormal.
Inferred to overlap with: Df(3R)BSC874.
Homozygous first instar larvae do not show any dorsal closure defects.
Inferred to overlap with: Df(3R)Exel6211.
Exelixis, Inc. determined the insertion site of the progenitor P{XP}d00762 to be Release 3 genomic coordinate 24927615 on chromosome arm 3R. This corresponds to Release 5 coordinate 3R:24938249 . The insertion site of the progenitor PBac{RB}e01987 is Release 5 coordinate 3R:24696033 . Consequently, the breakpoints of Df(3R)BSC806 predicted from the Release 5 genomic coordinates of the transposable element insertion sites are 3R:24696033 ;24938249 and the cytological breakpoints predicted from these coordinates are 98F1;98F10.